High-Throughput Screening of Patient-Derived Cultures Reveals Potential for Precision Medicine in Glioblastoma

ACS Medicinal Chemistry Letters

Volumn 6, Issue 8, 2015, Pages 948-952

  Quartararo, Christine E ^a   Reznik, Eduard ^a   DeCarvalho, Ana C ^b   Mikkelsen, Tom ^b   Stockwell, Brent R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Glioblastoma multiforme; laminin; neurosphere; personalized medicine; screening

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; AXITINIB; AZD 8055; B RAF KINASE; BORTEZOMIB; CASPASE 3; DACTOLISIB; K RAS PROTEIN; LAMININ; LENVATINIB; NAVITOCLAX; PROTEIN BCL 2; SELUMETINIB; TEMOZOLOMIDE; VENETOCLAX;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SOLUBILITY; EC50; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA; MULTIPLE MYELOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

BOVINAE;

EID: 84938904880     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.5b00128     Document Type: Article

References (14)

1. Dolecek, T. A.; Propp, J. M.; Stroup, N. E.; Kruchko, C. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009 Neuro. Oncol. 2012, 14 (Suppl 5) v1-v49 10.1093/neuonc/nos218
2. Shoemaker, R. H. The NCI60 Human Tumour Cell Line Anticancer Drug Screen Nat. Rev. Cancer 2006, 6 (10) 813-823 10.1038/nrc1951
3. Barretina, J.; Caponigro, G.; Stransky, N.; Venkatesan, K.; Margolin, A. a; Kim, S.; Wilson, C. J.; Lehár, J.; Kryukov, G. V.; Sonkin, D.; Reddy, A.; Liu, M.; Murray, L.; Berger, M. F.; Monahan, J. E.; Morais, P.; Meltzer, J.; Korejwa, A.; Jané-Valbuena, J.; Mapa, F. A.; Thibault, J.; Bric-Furlong, E.; Raman, P.; Shipway, A.; Engels, I. H.; Cheng, J.; Yu, G. K.; Yu, J.; Aspesi, P.; de Silva, M.; Jagtap, K.; Jones, M. D.; Wang, L.; Hatton, C.; Palescandolo, E.; Gupta, S.; Mahan, S.; Sougnez, C.; Onofrio, R. C.; Liefeld, T.; MacConaill, L.; Winckler, W.; Reich, M.; Li, N.; Mesirov, J. P.; Gabriel, S. B.; Getz, G.; Ardlie, K.; Chan, V.; Myer, V. E.; Weber, B. L.; Porter, J.; Warmuth, M.; Finan, P.; Harris, J. L.; Meyerson, M.; Golub, T. R.; Morrissey, M. P.; Sellers, W. R.; Schlegel, R.; Garraway, L. a. The Cancer Cell Line Encyclopedia Enables Predictive Modelling of Anticancer Drug Sensitivity Nature 2012, 483 (7391) 603-607 10.1038/nature11003
4. Garnett, M. J.; Edelman, E. J.; Heidorn, S. J.; Greenman, C. D.; Dastur, A.; Lau, K. W.; Greninger, P.; Thompson, I. R.; Luo, X.; Soares, J.; Liu, Q.; Iorio, F.; Surdez, D.; Chen, L.; Milano, R. J.; Bignell, G. R.; Tam, A. T.; Davies, H.; Stevenson, J. A.; Barthorpe, S.; Lutz, S. R.; Kogera, F.; Lawrence, K.; McLaren-Douglas, A.; Mitropoulos, X.; Mironenko, T.; Thi, H.; Richardson, L.; Zhou, W.; Jewitt, F.; Zhang, T.; O'Brien, P.; Boisvert, J. L.; Price, S.; Hur, W.; Yang, W.; Deng, X.; Butler, A.; Choi, H. G.; Chang, J. W.; Baselga, J.; Stamenkovic, I.; Engelman, J. A.; Sharma, S. V.; Delattre, O.; Saez-Rodriguez, J.; Gray, N. S.; Settleman, J.; Futreal, P. A.; Haber, D. a; Stratton, M. R.; Ramaswamy, S.; McDermott, U.; Benes, C. H. Systematic Identification of Genomic Markers of Drug Sensitivity in Cancer Cells Nature 2012, 483 (7391) 570-575 10.1038/nature11005
5. Li, A.; Walling, J.; Kotliarov, Y.; Center, A.; Steed, M. E.; Ahn, S. J.; Rosenblum, M.; Mikkelsen, T.; Zenklusen, J. C.; Fine, H. A. Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas Mol. Cancer Res. 2008, 6 (1) 21-30 10.1158/1541-7786.MCR-07-0280
6. Lee, J.; Kotliarova, S.; Kotliarov, Y.; Li, A.; Su, Q.; Donin, N. M.; Pastorino, S.; Purow, B. W.; Christopher, N.; Zhang, W.; Park, J. K.; Fine, H. A. Tumor Stem Cells Derived from Glioblastomas Cultured in bFGF and EGF More Closely Mirror the Phenotype and Genotype of Primary Tumors than Do Serum-Cultured Cell Lines Cancer Cell 2006, 9 (5) 391-403 10.1016/j.ccr.2006.03.030
7. Pollard, S. M.; Yoshikawa, K.; Clarke, I. D.; Danovi, D.; Stricker, S.; Russell, R.; Bayani, J.; Head, R.; Lee, M.; Bernstein, M.; Squire, J. A.; Smith, A.; Dirks, P. Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens Cell Stem Cell 2009, 4 (6) 568-580 10.1016/j.stem.2009.03.014
8. Danovi, D.; Folarin, A. A.; Baranowski, B.; Pollard, S. M. High Content Screening of Defined Chemical Libraries Using Normal and Glioma-Derived Neural Stem Cell Lines Methods Enzymol. 2012, 506, 311-329
9. Hasselbach, L. A.; Irtenkauf, S. M.; Lemke, N. W.; Nelson, K. K.; Berezovsky, A. D.; Carlton, E. T.; Transou, A. D.; Mikkelsen, T.; deCarvalho, A. C. Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry J. Visualized Exp. 2014, 83, e51088 10.3791/51088
10. Chen, D.; Frezza, M.; Schmitt, S.; Kanwar, J.; P Dou, Q. Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives Curr. Cancer Drug Targets 2011, 11 (3) 239-253 10.2174/156800911794519752
11. Beier, D.; Schulz, J. B.; Beier, C. P. Chemoresistance of Glioblastoma Cancer Stem Cells - Much More Complex than Expected Mol. Cancer 2011, 10 ((128).
12. Faber, A. C.; Coffee, E. M.; Costa, C.; Dastur, A.; Ebi, H.; Hata, A. N.; Yeo, A. T.; Edelman, E. J.; Song, Y.; Tam, A. T.; Boisvert, J. L.; Milano, R. J.; Roper, J.; Kodack, D. P.; Jain, R. K.; Corcoran, R. B.; Rivera, M. N.; Ramaswamy, S.; Hung, K. E.; Benes, C. H.; Engelman, J. A. mTOR Inhibition Specifically Sensitizes Colorectal Cancers with KRAS or BRAF Mutations to BCL-2/BCL-XL Inhibition by Suppressing MCL-1 Cancer Discovery 2014, 4 (1) 42-52 10.1158/2159-8290.CD-13-0315
13. Keith, C. T.; Borisy, A. A.; Stockwell, B. R. Multicomponent Therapeutics for Networked Systems Nat. Rev. Drug Discovery 2005, 4 (1) 71-78 10.1038/nrd1609
14. Bliss, C. I. The Toxicity of Poisons Applied Joints Ann. Appl. Biol. 1939, 26 (3) 585-615 10.1111/j.1744-7348.1939.tb06990.x